Patient Guide. This PATIENT GUIDE comes with your Binosto 70mg Effervescent Tablets pack. Please read it carefully.
|
|
- Sybil Ramsey
- 5 years ago
- Views:
Transcription
1 Patient Guide This PATIENT GUIDE comes with your Binosto 70mg Effervescent Tablets pack. Please read it carefully. BIN Patient Leaflet DL (Logo).indd 1 17/12/ :29
2 Binosto 70mg Effervescent Tablets (alendronic acid) You have been prescribed Binosto 70mg Effervescent Tablets by your doctor. They will have decided that you need Binosto because you have been diagnosed with a condition called osteoporosis. This PATIENT GUIDE provides you with information about Binosto and how you should take it. It also tells you a little about osteoporosis and provides you with useful information sources, such as websites, that may prove useful. Please make sure to also read the Patient Information Leaflet that came with your Binosto pack. What is Binosto? Binosto is a round whitish effervescent tablet that contains the active ingredient alendronic acid. Alendronic acid belongs to a group of medicines called bisphosphonates, a type of medicine that has been specifically designed to help stop or prevent the effects that osteoporosis can have on your bones. Bisphosphonates slow the process that leads to bone being broken down by the body. This helps stop bone from becoming fragile and so decreases the risk of fractures. Binosto dissolves in water to produce an effervescent solution that you drink. The normal dosage is usually one tablet once a week, though your doctor will advise you on what they feel is most suitable for you and your bones. The dispensing label on the outside of the pack will confirm the dosage your doctor has prescribed for you. You can only get Binosto with a prescription from your doctor. BIN Patient Leaflet DL (Logo).indd /12/ :29
3 Why have I been prescribed Binosto? Binosto is prescribed for women who have been diagnosed with postmenopausal osteoporosis. Osteoporosis causes a decline in bone mineral density, which results in your bones becoming weak and fragile. Weak bones are more likely to break or fracture. Binosto is a medicine designed to prevent this decline in bone strength, and help reduce risk of fracture. If you have been diagnosed as having osteoporosis it may be because you have already suffered a bone fracture. Taking Binosto, along with adequate levels of calcium and vitamin D, may prevent any further fractures from happening. Bone density comparison How does Binosto work? Binosto works by slowing down the body s process of breaking down old bone, giving the bone-forming cells time to rebuild normal bone. Of course, to rebuild normal bone, your body needs good, regular sources of calcium and vitamin D, so your doctor may prescribe these for you to take alongside your Binosto prescription. When and how to take Binosto Unless otherwise stated, your doctor will have prescribed you one Binosto tablet to be taken once a week. In some circumstances the active ingredient in Binosto, called alendronic acid, can cause gastric side effects. Alendronic acid is also known to interact with some other medicines and foods. Although Binosto has been formulated to limit the potential for gastric side effects, you still need to take it as directed. NORMAL BONE DENSITY OSTEOPOROSIS 1 Before breakfast, dissolve one tablet in 120ml of water (not sparkling). It is important that the tablet is dissolved completely, as this ensures the whole tablet goes straight into your stomach and prevents any residual tablet lying in your oesophagus when you swallow it. Never chew or suck your Binosto tablet. 2 Swallow the whole water mixture, followed by at least 30ml (one third of a glass) of plain water. Additional plain water can be taken if required. 3 Afterwards, it is important to sit or stand upright, and avoid eating anything for the next 30 minutes. This should help the medicine reach your stomach and reduce the risk of unpleasant side effects, or interactions with food or other medicines. If you forget to take your tablet on the right day, don t worry, you can take it the next morning you remember. Then continue with your prescribed (weekly or otherwise) dose as before. However, do not take two tablets together. BIN Patient Leaflet DL (Logo).indd /12/ :29
4 Are there any side-effects? The possible side-effects of taking Binosto are mainly gastro-intestinal, such as stomach pain, dyspepsia (wind/indigestion), acid reflux and feelings of nausea. Taking your medicine as described above and carefully following the instructions in the patient information leaflet should minimise these effects. However if you experience any of these side effects, please contact your doctor or pharmacist for advice. Please read your Package Leaflet for more information on side-effects. What else can I do to help strengthen my bones? Healthy eating and good exercise are the best starting points for maintaining healthy bones. Like the rest of your body, the health and strength of your bones will benefit from a balanced diet that contains protein, calcium and vitamin D. You can get these from foodstuffs such as dairy products, oily fish, eggs and fortified cereals. Some patients may find it difficult to get sufficient calcium and/or vitamin D from their diet so it may be an idea to talk with your doctor about having a calcium and/or vitamin D supplement prescribed alongside Binosto. You can also report side-effects directly via the Yellow Card Scheme at By reporting side-effects you can help provide more information on the safety of this medicine. Do not stop taking Binosto unless your doctor tells you to do so. What happens if I stop taking it? The effects of not taking your Binosto tablets will develop over a medium to long period of time. As the body begins to break down bone structure again, your bones will weaken and can become susceptible to fracture. Fractures can cause you undue pain and discomfort but also may result in long-term consequences on mobility. Remember do not stop taking Binosto unless your doctor tells you to do so. The type of exercise where you support the weight of your own body, such as jogging or walking, can be especially useful for bone health. Only do such activities if you feel fit enough to do so. Further advice on self-help can be obtained from the National Osteoporosis Society website More useful information is also available on where you can sign up for a reminder service and access more information about Binosto and osteoporosis. You ll be asked to type in the batch code found on your Binosto pack (next to the expiry date) just to confirm you have been prescribed Binosto. BIN Patient Leaflet DL (Logo).indd /12/ :29
5 Further information This leaflet is also available in several other languages as well as in large font for the partially sighted. For further information on Binosto, please speak to your doctor or pharmacist. Do not stop taking your medication unless your doctor tells you to. Alternatively contact: Internis Pharmaceuticals Ltd. c/o Thornton & Ross Linthwaite Huddersfield HD7 5QH Tel: This PATIENT GUIDE has been produced as a service to medicine by Internis Pharmaceuticals Ltd. Should you need further information about osteoporosis or feel the need to talk to someone about your diagnosis, the National Osteoporosis Society has a helpline staffed by specialist nurses. Just call them on or send an enquiry to nurses@nos.org.uk. Date of preparation: December BIN-0008 BIN Patient Leaflet DL (Logo).indd 8 17/12/ :29
Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium
Package leaflet: Information for the patient Risedronate sodium 35 mg film-coated tablets Risedronate sodium Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 5 mg film-coated tablets risedronate sodium
PACKAGE LEAFLET: INFORMATION FOR THE USER Risedronat Jubilant 5 mg film-coated tablets risedronate sodium Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 35 mg film-coated tablets risedronate sodium
PACKAGE LEAFLET: INFORMATION FOR THE USER Risedronat Jubilant 35 mg film-coated tablets risedronate sodium Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Alendroninezuur Mylan 70 mg, tabletten. (sodium alendronate trihydrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER Alendroninezuur Mylan 70 mg, tabletten (sodium alendronate trihydrate) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet.
More informationDorset Pathway for the use of bisphosphonates for post-menopausal women with breast cancer. Summary
Summary Appendix 1: Selection of patients suitable for adjuvant bisphosphonates* Appendix 2 Adjuvant Bisphosphonates for Early Breast Cancer Information for patients This leaflet is intended to support
More informationStrong bones after 50 Fracture liaison services explained A guide for patients, carers and families
Strong bones after 50 Fracture liaison services explained A guide for patients, carers and families What the NHS should provide for people over 50 who have broken a bone after falling from standing height
More informationPackage leaflet: Information for the patient
Package leaflet: Information for the patient UK Rocaltrol 0.25 microgram Capsules Rocaltrol 0.5 microgram Capsules Calcitriol Roche Read all of this leaflet carefully before you start taking this medicine
More informationStrong bones after 50 Fracture liaison services explained A guide for patients, carers and families
What the NHS should provide for people over 50 who have broken a bone after falling from standing height or less. Feedback Strong bones after 50 A guide for patients, carers and families What the NHS should
More informationActonel risedronate sodium
risedronate sodium Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information. It does not take the place
More informationPackage leaflet: Information for the patient. Destolit 150 mg tablets Ursodeoxycholic acid
Package leaflet: Information for the patient Destolit 150 mg tablets Ursodeoxycholic acid Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationA Patient Information Guide My Guide to HCV treatment and care. Helpful information for patients who have been prescribed MAVIRET
A Patient Information Guide My Guide to HCV treatment and care Helpful information for patients who have been prescribed MAVIRET The information in this booklet does not replace the Patient Information
More informationUnderstanding Bone. Osteoporosis
Apo-Alendronate Once Tablets contains the active ingredient, Alendronate sodium For a copy of a large print leaflet, ph: 1800 195 055 Consumer Medicine Information What is in this leaflet This leaflet
More informationPackage leaflet: Information for the user. Alendronat 1A Farma Veckotablett 70 mg Film-coated tablets Alendronic acid
Package leaflet: Information for the user Alendronat 1A Farma Veckotablett 70 mg Film-coated tablets Alendronic acid Read all of this leaflet carefully before you start taking this medicine because it
More informationOsteoporosis Care Sheet
Osteoporosis Care Sheet Serial no Keynote for Osteoporosis Care Not to emphasize side effect too much. No need to explain too many things at the first counseling. Support patient's self care! 1) Diagnosis
More informationPackage leaflet: Information for the patient. Optinate 5 mg film-coated tablets risedronate sodium
Package leaflet: Information for the patient Optinate 5 mg film-coated tablets risedronate sodium Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Alendronic Acid 10 mg Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Alendronic Acid 10 mg Tablets (Alendronic Acid) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read
More informationLYSOBACT COMPLETE SPRAY ( ) mg / ml Oromucosal spray, solution
PACKAGE LEAFLET: INFORMATION FOR THE USER LYSOBACT COMPLETE SPRAY (20 + 1.5 + 0.5) mg / ml Oromucosal spray, solution LYSOZYME, CETYLPYRIDINIUM, LIDOCAINE This leaflet is a copy of the Summary of Product
More informationMedication Guide ACTONEL (AK-toh-nel) (risedronate sodium) Tablets
Medication Guide ACTONEL (AK-toh-nel) (risedronate sodium) Tablets Read the Medication Guide that comes with ACTONEL before you start taking it and each time you get a refill. There may be new information.
More informationUnderstanding NICE guidance. NICE technology appraisal guidance advises on when and how drugs and other treatments should be used in the NHS.
Understanding NICE guidance Information for people who use NHS services Alendronate, etidronate, risedronate, strontium ranelate and raloxifene for preventing bone fractures in postmenopausal women with
More informationIt is used to prevent or treat soft, brittle bones (osteoporosis). It may be g iven to you for other reasons. Talk with the doctor.
PATIENT & CAREGIVER EDUCATION Alendronate Brand Names: US Binosto; Fosamax Brand Names: Canada Fosamax What is this drug used for? It is used to prevent or treat soft, brittle bones (osteoporosis). It
More informationTeriparatide (also known as Forsteo) Rheumatology Department Patient Information Leaflet
Teriparatide (also known as Forsteo) Rheumatology Department Patient Information Leaflet Introduction This information leaflet is about a medicine called teriparatide (also known as Forsteo) which is used
More informationPackage leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate
PACKAGE LEAFLET Package leaflet: Information for the patient Calcium Folinate 15 mg Tablets calcium folinate Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPYRIDOSTIGMINE LIME TM 60MG TABLETS Pyridostigmine bromide
PACKAGE LEAFLET PYRIDOSTIGMINE LIME TM 60MG TABLETS Pyridostigmine bromide Patient Information Leaflet READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. Keep this leaflet. You may
More informationPATIENT INFORMATION BOOKLET
PATIENT INFORMATION BOOKLET GETTING STARTED WITH YOUR MEDICINES TIVICAY (dolutegravir) + lamivudine Tivicay is subject to additional monitoring. This will allow quick identification of new safety information.
More informationPATIENT INFORMATION LEAFLET. Urea 10% w/w Cream
PATIENT INFORMATION LEAFLET Urea 10% w/w Cream Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you still
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 30 mg film-coated tablets risedronate sodium
PACKAGE LEAFLET: INFORMATION FOR THE USER Risedronat Jubilant 30 mg film-coated tablets risedronate sodium Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPradaxa. [dabigatran etexilate] patient support booklet
Pradaxa [dabigatran etexilate] patient support booklet Important information about your medication and how to take it to help you reduce your risk of stroke associated with atrial fibrillation You have
More informationRANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets RANITIDINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information
More informationMedicines in Scotland: What s the right treatment for me? Information for patients and the public
Medicines in Scotland: What s the right treatment for me? Information for patients and the public You can read and download this document from our website. We are happy to consider requests for other languages
More informationBone density scanning and osteoporosis
Bone density scanning and osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break
More informationEntocort. Budesonide 3 mg capsules CONSUMER MEDICINE INFORMATION
Entocort Budesonide 3 mg capsules CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some of the common questions people ask about Entocort. It does not contain all the information
More informationMethotrexate for inflammatory bowel disease: what you need to know
Methotrexate for inflammatory bowel disease: what you need to know This leaflet aims to answer your questions about taking methotrexate for inflammatory bowel disease (IBD). If you have any questions or
More informationBonefos 400 mg capsules sodium clodronate
Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end
More informationPackage leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides
Package leaflet: Information for the user SenEase 7.5 mg tablets Sennosides Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep
More informationMEDICATION GUIDE. Boniva (bon-ee-va) (ibandronate sodium) Tablets
MEDICATION GUIDE Boniva (bon-ee-va) (ibandronate sodium) Tablets Read the Medication Guide that comes with BONIVA before you start taking it and each time you get a refill. There may be new information.
More informationPackage Leaflet: Information for the User
Package Leaflet: Information for the User KLEAN-PREP 69g Sachet Powder for Oral Solution Macrogol 3350, Sodium sulphate anhydrous, Sodium bicarbonate, Sodium chloride and Potassium chloride Read all of
More informationSIOFOR mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER SIOFOR 850 850mg film-coated tablets METFORMIN HYDROCHLORIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for
More informationWhat is in this leaflet
Contains the active ingredient risedronate sodium (as hemipentahydrate) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet carefully
More informationPATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate
PATIENT INFORMATION LEAFLET Calcichew* 500 mg Chewable Tablets calcium carbonate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationRABEPRAZOL 10mg and 20mg Gastro-resistant Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet
More information2 What you need to know before you take Zantac
Package leaflet: Information for the user Zantac Tablets 150 mg and 300 mg ranitidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationCREON 25,000 Capsules Pancreatic Extract Enteric-Coated Minimicrospheres
CREON 25,000 Capsules Pancreatic Extract Enteric-Coated Minimicrospheres Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions about Creon 25,000 Capsules.
More informationMotens 2 mg and 4 mg Tablets lacidipine
Package leaflet: Information for the user Motens 2 mg and 4 mg Tablets lacidipine Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationMoving forward with your epilepsy treatment
Moving forward with your epilepsy treatment Answers to frequently asked questions about Episenta (Prolonged release sodium valproate) for patients prescribed this treatment This information is not a substitute
More informationPackage Leaflet: Information for the User. Kemadrin tablets 5 mg procyclidine hydrochloride
Package Leaflet: Information for the User Kemadrin tablets 5 mg procyclidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationYour treatment with XELJANZ
Your treatment with XELJANZ (tofacitinib citrate) THIS BROCHURE HAS BEEN PRODUCED FOR PATIENTS WHO HAVE BEEN PRESCRIBED XELJANZ. BEFORE USING XELJANZ, PLEASE REVIEW THE PACKAGE LEAFLET FOR THIS MEDICINAL
More informationFOSAMAX(R) Once Weekly
FOSAMAX(R) Once Alendronate sodium Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about FOSAMAX Once. It is particularly important that you read the sections
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)
PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride) Please read this information carefully before you start to take your medicine.
More informationGLUCOPHAGE 500 mg mg mg
GLUCOPHAGE 500 mg - 750 mg - 1000 mg Prolonged release tablets metformin hydrochloride This medicine is intended for adult patients only Read all of this leaflet carefully before you start taking this
More informationImodium 1 mg/5 ml oral solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Imodium 1 mg/5 ml oral solution Loperamide hydrochloride Imodium is a registered trademark Read all of this leaflet carefully before you start using this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate) Pfizer Logo Read all of this leaflet carefully before you start taking this
More informationConsumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.
Clindamycin hydrochloride Capsules 150 mg What is in this leaflet Consumer Medicine Information TOPICIL Please read this leaflet carefully before you start using Topicil Capsules. This leaflet answers
More informationPackage Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution
Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution Read all of this leaflet carefully before you give this medicine to your child because it contains important
More informationIt does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.
Actonel Combi D risedronate sodium, calcium carbonate, cholecalciferol (Vitamin D3) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Actonel Combi
More informationSIOFOR mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER SIOFOR 1000 1000mg film-coated tablets For use in children from 10 years and adults METFORMIN HYDROCHLORIDE This leaflet is a copy of the Summary of Product Characteristics
More information2 What you need to know before you take Osbonelle 150 mg Do not take Osbonelle 150 mg:
Package leaflet: Information for the patient Osbonelle 150 mg film-coated tablets ibandronic acid Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPackage leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate
PACKAGE LEAFLET 1 Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationRheumatology Department Patient Information Leaflet. Introduction Prolia (denosumab) is a treatment for post-menopausal osteoporosis.
Prolia (denosumab) Rheumatology Department Patient Information Leaflet Introduction Prolia (denosumab) is a treatment for post-menopausal osteoporosis. What is osteoporosis? Osteoporosis is a condition
More informationMycophenolate mofetil: risks of miscarriage and birth defects. Patient guide
Mycophenolate mofetil: risks of miscarriage and birth defects Patient guide Key points to remember Mycophenolate mofetil causes birth defects and miscarriages Follow the contraceptive advice given to you
More informationTransiderm-Nitro 5 and 10 (glyceryl trinitrate)
Transiderm-Nitro 5 and 10 (glyceryl trinitrate) Patient Information Leaflet What you need to know about Transiderm-Nitro 5 and 10 Your doctor has decided that you need this medicine to help treat your
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Aciclovir 400 mg Tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this
More informationFOSAMAX Once Weekly Alendronate sodium
Alendronate sodium Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It is particularly important that you read the sections "When to take it" and
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil
PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationRisedronate Winthrop EC Combi D risedronate sodium (enteric-coated), calcium carbonate, cholecalciferol (Vitamin D3)
risedronate sodium (enteric-coated), calcium carbonate, cholecalciferol (Vitamin D3) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Risedronate Winthrop
More informationEpilepsy is a condition where you have repeated seizures (fits). There are many different types of seizures, ranging from mild to severe.
CONSUMER MEDICINE INFORMATION Levetiracetam generichealth Levetiracetam tablets What is in this leaflet Please read this leaflet carefully before you take this medicine. This leaflet answers some common
More informationIBS Relief 135 mg Tablets Mebeverine Hydrochloride
PATIENT INFORMATION LEAFLET IBS Relief 135 mg Tablets Mebeverine Hydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription.
More informationCREON Capsules Pancreatic Extract Enteric-Coated Minimicrospheres
CREON Capsules Pancreatic Extract Enteric-Coated Minimicrospheres Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions about Creon 10,000, Creon 25,000
More informationPRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate
Package leaflet: Information for the user PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Read all of this leaflet carefully before you start using this medicine because it contains important
More informationAPO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate)
APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER Calcium Sandoz 500 mg, effervescent tablets Calcium Sandoz 1000 mg, effervescent tablets Calcium Read all of this leaflet carefully because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets Betahistine dihydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)
PACKAGE LEAFLET: INFORMATION FOR THE USER DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral) Read all of this leaflet carefully before you start using
More information2. What you need to know before you are given Konakion MM. Package Leaflet: Information for the patient
Package Leaflet: Information for the patient Konakion MM Ampoules 10mg/ml solution for injection Phytomenadione (vitamin K 1 ) Roche Read all of this leaflet carefully before you start taking this medicine
More informationPackage leaflet: Information for the patient. ERWINASE 10,000 Units, Powder for solution for injection
PACKAGE LEAFLET 1 Package leaflet: Information for the patient ERWINASE 10,000 Units, Powder for solution for injection (Asparaginase from Erwinia chrysanthemi; Erwinia L-asparaginase) Read all of this
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER SALAGEN 5 mg film-coated tablets Pilocarpine hydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER DYSPORT 500 units Powder for solution for injection Clostridium botulinum type A toxin-haemagglutinin complex Read all of this leaflet carefully, before you start
More informationPackage leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid
Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid Read all of this leaflet carefully before you are given this medicine because it contains important
More informationVermox 100 mg/5 ml oral suspension
PACKAGE LEAFLET: INFORMATION FOR THE USER Vermox 100 mg/5 ml oral suspension Mebendazole Vermox is a registered trademark Read all of this leaflet carefully before you start using this medicine. Keep this
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE
PACKAGE LEAFLET: INFORMATION FOR THE USER BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to
More information1. What Betahistine dihydrochloride tablets is and what it is used for
Package leaflet: Information for the user Betahistine dihydrochloride 8 mg tablets Betahistine dihydrochloride 16 mg tablets Betahistine dihydrochloride Read all of this leaflet carefully before you start
More informationFOSAMAX Alendronate sodium
FOSAMAX Alendronate sodium Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about FOSAMAX. It is particularly important that you read the sections "When
More informationALENDRONATE PLUS D3 SANDOZ Contains the active ingredient alendronate sodium and colecalciferol
Contains the active ingredient alendronate sodium and colecalciferol Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine. This leaflet answers
More informationPackage leaflet: Information for the user. Carmellose sodium
Package leaflet: Information for the user CELLUVISC 0.5% w/v, eye drops, solution, unit dose Carmellose sodium Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium
Package leaflet: Information for the patient Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion Active substance: Heparin Sodium Read all of this leaflet carefully before you are given
More informationConsumer Medicine Information
MAXOLON Consumer Medicine Information Metoclopramide hydrochloride 10mg Tablet What is in this leaflet This leaflet answers some common questions about Maxolon. It does not contain all the available information.
More informationJINARC (tolvaptan) Patient/carer education brochure
JINARC (tolvaptan) Patient/carer education brochure This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium
PACKAGE LEAFLET: INFORMATION FOR THE USER Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPackage leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)
Package leaflet: Information for the patient Bumetanide 1 mg and 5 mg Tablets (bumetanide) Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationUnderstanding bone metastases and XGEVA
Understanding bone metastases and XGEVA Contents About bone metastases 3 About XGEVA 5 Dealing with common side effects of XGEVA 8 FAs about living with bone metastases 9 Notes 10 About bone metastases
More informationThis leaflet answers some common questions about ATIVAN. It does not contain all of the available information.
Ativan Lorazepam Tablets Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ATIVAN. It does not contain all of the available information. It does not
More informationEndoscopy Unit MOVIPREP. Afternoon Appointment - GASTROSCOPY AND COLONOSCOPY. Information for patients
Endoscopy Unit MOVIPREP Afternoon Appointment - GASTROSCOPY AND COLONOSCOPY Information for patients This leaflet contains important information about MOVIPREP. You have been given MOVIPREP to cleanse
More informationPackage leaflet: Information for the patient. Alendronic Acid 70 mg Tablets. sodium alendronate
Package leaflet: Information for the patient Alendronic Acid 70 mg Tablets sodium alendronate Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the user. Risedronate Bluefish 35 mg film-coated tablets Risedronate sodium
Package leaflet: Information for the user Risedronate Bluefish 35 mg film-coated tablets Risedronate sodium Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ILAXTEN 20 MG TABLETS bilastine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationcontains the active ingredient diazepam It does not contain all the available information.
VALIUM pronounced (val-i-um) contains the active ingredient diazepam Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about VALIUM. It does not contain all
More informationPyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.
PACKAGE LEAFLET Page 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE USER Pyrazinamide 500 mg Tablets * Pyrazinamide Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.
More informationIt does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.
DUCENE pronounced (dew-seen) contains the active ingredient diazepam Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about DUCENE tablets. It does not contain
More information